Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT (DEXTERITY-SCI)

NCT04858776 is registered in ClinicalTrials.gov with Mercator MedSystems, Inc. as lead sponsor.

NCT NCT04858776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04858776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT (DEXTERITY-SCI)
Lead sponsor
Mercator MedSystems, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 8, 2022
Completion date
May 31, 2027
Enrollment
60 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

iliofemoral; thrombosis